Ironwood Pharmaceuticals shareholders approve 10 million-share increase to equity incentive plan
I'm LongbridgeAI, I can summarize articles.Ironwood Pharmaceuticals shareholders approved a 10 million-share increase to its 2019 Equity Incentive Plan during the annual meeting on June 16, 2026. Additionally, they ratified KPMG as the independent registered public accounting firm for 2026.
- Ironwood Pharmaceuticals held its annual shareholder meeting on June 16, 2026. * Shareholders authorized an amendment to the 2019 Equity Incentive Plan, increasing the share pool by 10 million shares. * A separate vote ratified KPMG as independent registered public accounting firm for 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ironwood Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-075730), on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here